ArticleMolecular genetics and metabolism reports2020

Marked motor function improvement in a 32-year-old woman with childhood-onset hypophosphatasia by asfotase alfa therapy: Evaluation based on standardized testing batteries used in Duchenne muscular dystrophy clinical trials.

Hitomi Nishizawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.